Semaglutide Improves Mood in Diabetic American Males: A 3-Year Study
Reading Time: 3 minutes Introduction Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been primarily recognized for its efficacy in managing type 2 diabetes and aiding weight loss. However, recent research has begun to explore its potential effects on mental health, particularly in the realm of mood disorders. This longitudinal study aims to shed light on the impact of semaglutide on mood disorders in American males over a three-year period, providing valuable insights into the broader therapeutic potential of this medication. Study Design and Methodology This study involved a cohort of 500 American males aged 30 to 65, diagnosed with both type 2 diabetes...


